0      0


Emerging Technologies


Jun 24, 2020 12:00am ‐ Sep 11, 2020 6:08am


Credits: None available.

Description

Emerging Technologies

Emerging Technologies The session brings together industrial case studies from practitioners who have delivered innovative solutions to enable the adoption of continuous processing within their companies.

  • Commercializing New Chemical Technologies in Flow
    Moiz Diwan, PhD, Director, Head of Enabling Technology Group
    AbbVie  
  • Continuous Processing for the Manufacture of Active Pharmaceutical Ingredients
    Martin Johnson, PhD, Sr. Engineering Advisor
    Eli Lilly & Company
  • The Use of Kinetic Modelling to Define a Design Space for a Continuous Process
    Peter Shapland, PhD, Scientific Leader, R&D Medicinal Science & Technology
    GSK Stevenage

Moderator(s):

  • Malcolm Berry, PhD, Continuous Chemistry Team Manager, MB Chemistry Consulting, Ltd.

Speaker(s):

  • Moiz Diwan, PhD, Director, Pharmaceutical Development Research & Development, AbbVie
  • Martin Johnson, PhD, Sr. Engineering Advisor, Eli Lilly and Company
  • Peter Shapland, PhD, Scientific Leader, R&D Medicinal Science and Technology, GSK Stevenage

Credits

Credits: None available.

You must be logged in and own this session in order to post comments.